Status:
COMPLETED
Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers
Lead Sponsor:
Egyptian Center for Research and Regenerative Medicine
Collaborating Sponsors:
Cairo University
National Research Centre, Egypt
Conditions:
COVID
Corona Virus Infection
Eligibility:
All Genders
18-60 years
Brief Summary
The medical and paramedical staff of the front-line services are potentially exposed to SARS-CoV-2. Therefore, despite the application of standard protective measures, it is possible that a certain nu...
Eligibility Criteria
Inclusion
- Not previously diagnosed with COVID-19 except for convalescents
- Not currently symptomatic with fever or respiratory symptoms (cough, dyspnea)
Exclusion
- Patients with fever or respiratory symptoms (cough, dyspnea)
- Refusal to give informed consent, or contraindication to venipuncture.
Key Trial Info
Start Date :
June 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
1546 Patients enrolled
Trial Details
Trial ID
NCT04424017
Start Date
June 7 2020
End Date
October 30 2020
Last Update
March 9 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
ECRRM
Cairo, Egypt, 32
2
Faculty of Medicine, Cairo University
Cairo, Egypt